{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T11:41:38Z","timestamp":1772710898076,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Radiol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00247-019-04511-4","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T13:04:50Z","timestamp":1571231090000},"page":"1565-1573","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Surveillance imaging in pediatric lymphoma"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2092-2219","authenticated-orcid":false,"given":"Stephan D.","family":"Voss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell S.","family":"Cairo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,16]]},"reference":[{"key":"4511_CR1","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/bjh.15764","volume":"185","author":"MS Cairo","year":"2019","unstructured":"Cairo MS, Beishuizen A (2019) Childhood, adolescent and young adult non-Hodgkin lymphoma: current perspectives. Br J Haematol 185:1021\u20131042","journal-title":"Br J Haematol"},{"key":"4511_CR2","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1182\/blood-2006-07-036673","volume":"109","author":"C Patte","year":"2007","unstructured":"Patte C, Auperin A, Gerrard M et al (2007) Results of the randomized international FAB\/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood 109:2773\u20132780","journal-title":"Blood"},{"key":"4511_CR3","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/bjh.14035","volume":"173","author":"MS Cairo","year":"2016","unstructured":"Cairo MS, Pinkerton R (2016) Childhood, adolescent and young adult non-Hodgkin lymphoma: state of the science. Br J Haematol 173:507\u2013530","journal-title":"Br J Haematol"},{"key":"4511_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1200\/JCO.2010.33.3369","volume":"30","author":"MS Cairo","year":"2012","unstructured":"Cairo MS, Sposto R, Gerrard M et al (2012) Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (>\/= 15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB LMB 96 study. J Clin Oncol 30:387\u2013393","journal-title":"J Clin Oncol"},{"key":"4511_CR5","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/bjh.13372","volume":"169","author":"L Giulino-Roth","year":"2015","unstructured":"Giulino-Roth L, Keller FG, Hodgson DC et al (2015) Current approaches in the management of low risk Hodgkin lymphoma in children and adolescents. Br J Haematol 169:647\u2013660","journal-title":"Br J Haematol"},{"key":"4511_CR6","doi-asserted-by":"crossref","unstructured":"Goldman S, Smith L, Anderson JR et al (2013) Rituximab and FAB\/LMB 96 chemotherapy in children with stage III\/IV B-cell non-Hodgkin lymphoma: a Children's Oncology Group report. Leukemia 27:1174\u20131177","DOI":"10.1038\/leu.2012.255"},{"key":"4511_CR7","doi-asserted-by":"crossref","unstructured":"Goldman S, Smith L, Galardy P et al (2014) Rituximab with chemotherapy in children and adolescents with central nervous system and\/or bone marrow-positive Burkitt lymphoma\/leukaemia: a Children's Oncology Group report. Br J Haematol 167:394\u2013401","DOI":"10.1111\/bjh.13040"},{"key":"4511_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/PPO.0000000000000345","volume":"24","author":"J Hochberg","year":"2018","unstructured":"Hochberg J, Cairo MS (2018) Lymphoma in adolescents and young adults: current perspectives. Cancer J 24:285\u2013300","journal-title":"Cancer J"},{"key":"4511_CR9","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/pbc.24423","volume":"60","author":"KM Kelly","year":"2013","unstructured":"Kelly KM, Hodgson D, Appel B et al (2013) Children's oncology Group's 2013 blueprint for research: Hodgkin lymphoma. Pediatr Blood Cancer 60:972\u2013978","journal-title":"Pediatr Blood Cancer"},{"key":"4511_CR10","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1002\/cncr.28748","volume":"120","author":"MA Smith","year":"2014","unstructured":"Smith MA, Altekruse SF, Adamson PC et al (2014) Declining childhood and adolescent cancer mortality. Cancer 120:2497\u20132506","journal-title":"Cancer"},{"key":"4511_CR11","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00247-011-2108-1","volume":"41","author":"SC Kaste","year":"2011","unstructured":"Kaste SC (2011) Oncological imaging: tumor surveillance in children. Pediatr Radiol 41:505\u2013508","journal-title":"Pediatr Radiol"},{"key":"4511_CR12","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1007\/s00247-009-1404-5","volume":"39","author":"SD Voss","year":"2009","unstructured":"Voss SD, Reaman GH, Kaste SC et al (2009) The ALARA concept in pediatric oncology. Pediatr Radiol 39:1142\u20131146","journal-title":"Pediatr Radiol"},{"key":"4511_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/pbc.24757","volume":"61","author":"K McHugh","year":"2014","unstructured":"McHugh K, Roebuck DJ (2014) Pediatric oncology surveillance imaging: two recommendations. Abandon CT scanning, and randomize to imaging or solely clinical follow-up. Pediatr Blood Cancer 61:3\u20136","journal-title":"Pediatr Blood Cancer"},{"key":"4511_CR14","doi-asserted-by":"crossref","unstructured":"Keller FG, Castellino SM, Chen L et al (2018) Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: a report from the Children's Oncology Group. Cancer 124:3210\u20133219","DOI":"10.1002\/cncr.31519"},{"key":"4511_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3109\/08880018.2012.684198","volume":"29","author":"N Rathore","year":"2012","unstructured":"Rathore N, Eissa HM, Margolin JF et al (2012) Pediatric Hodgkin lymphoma: are we over-scanning our patients? Pediatr Hematol Oncol 29:415\u2013423","journal-title":"Pediatr Hematol Oncol"},{"key":"4511_CR16","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s11899-013-0168-z","volume":"8","author":"SD Voss","year":"2013","unstructured":"Voss SD (2013) Surveillance imaging in pediatric Hodgkin lymphoma. Curr Hematol Malig Rep 8:218\u2013225","journal-title":"Curr Hematol Malig Rep"},{"key":"4511_CR17","doi-asserted-by":"publisher","unstructured":"Banerjee P, Rossi MG, Anghelescu DL et al (2019) Association between anesthesia exposure and neurocognitive and neuroimaging outcomes in long-term survivors of childhood acute lymphoblastic leukemia. JAMA Oncol. https:\/\/doi.org\/10.1001\/jamaoncol.2019.1094","DOI":"10.1001\/jamaoncol.2019.1094"},{"key":"4511_CR18","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1002\/cncr.20896","volume":"103","author":"L Howell","year":"2005","unstructured":"Howell L, Mensah A, Brennan B et al (2005) Detection of recurrence in childhood solid tumors. Cancer 103:1274\u20131279","journal-title":"Cancer"},{"key":"4511_CR19","doi-asserted-by":"crossref","unstructured":"Voss SD, Chen L, Constine LS et al (2012) Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology Group. J Clin Oncol 30:2635\u20132640","DOI":"10.1200\/JCO.2011.40.7841"},{"key":"4511_CR20","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1002\/pbc.24568","volume":"60","author":"AM Friedmann","year":"2013","unstructured":"Friedmann AM, Wolfson JA, Hudson MM et al (2013) Relapse after treatment of pediatric Hodgkin lymphoma: outcome and role of surveillance after end of therapy. Pediatr Blood Cancer 60:1458\u20131463","journal-title":"Pediatr Blood Cancer"},{"key":"4511_CR21","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/leu.2014.194","volume":"29","author":"P Satwani","year":"2015","unstructured":"Satwani P, Jin Z, Martin PL et al (2015) Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma. Leukemia 29:448\u2013455","journal-title":"Leukemia"},{"key":"4511_CR22","doi-asserted-by":"crossref","unstructured":"Kapke JT, Epperla N, Shah N et al (2017) Effect of routine surveillance imaging on the outcomes of patients with classical Hodgkin lymphoma after autologous hematopoietic cell transplantation. Clin Lymphoma Myeloma Leuk 17:408\u2013414","DOI":"10.1016\/j.clml.2017.05.005"},{"key":"4511_CR23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11899-015-0277-y","volume":"10","author":"JT Sandlund","year":"2015","unstructured":"Sandlund JT (2015) Non-Hodgkin lymphoma in children. Curr Hematol Malig Rep 10:237\u2013243","journal-title":"Curr Hematol Malig Rep"},{"key":"4511_CR24","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/bjh.15491","volume":"182","author":"M Cairo","year":"2018","unstructured":"Cairo M, Auperin A, Perkins SL et al (2018) Overall survival of children and adolescents with mature B cell non-Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB\/LMB 96: a report from the FAB\/LMB 96 study group. Br J Haematol 182:859\u2013869","journal-title":"Br J Haematol"},{"key":"4511_CR25","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1200\/JCO.2014.59.7203","volume":"33","author":"A Rosolen","year":"2015","unstructured":"Rosolen A, Perkins SL, Pinkerton CR et al (2015) Revised international pediatric non-Hodgkin lymphoma staging system. J Clin Oncol 33:2112\u20132118","journal-title":"J Clin Oncol"},{"key":"4511_CR26","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1200\/JCO.2014.59.0745","volume":"33","author":"JT Sandlund","year":"2015","unstructured":"Sandlund JT, Guillerman RP, Perkins SL et al (2015) International pediatric non-Hodgkin lymphoma response criteria. J Clin Oncol 33:2106\u20132111","journal-title":"J Clin Oncol"},{"key":"4511_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3109\/08880018.2013.834400","volume":"31","author":"HM Eissa","year":"2014","unstructured":"Eissa HM, Allen CE, Kamdar K et al (2014) Pediatric Burkitt's lymphoma and diffuse B-cell lymphoma: are surveillance scans required? Pediatr Hematol Oncol 31:253\u2013257","journal-title":"Pediatr Hematol Oncol"},{"key":"4511_CR28","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1200\/JCO.2015.62.0229","volume":"33","author":"TC El-Galaly","year":"2015","unstructured":"El-Galaly TC, Jakobsen LH, Hutchings M et al (2015) Routine imaging for diffuse large B-cell lymphoma in first complete remission does not improve post-treatment survival: a Danish-Swedish population-based study. J Clin Oncol 33:3993\u20133998","journal-title":"J Clin Oncol"},{"key":"4511_CR29","doi-asserted-by":"publisher","first-page":"e851","DOI":"10.1542\/peds.2009-2675","volume":"126","author":"BA Ahmed","year":"2010","unstructured":"Ahmed BA, Connolly BL, Shroff P et al (2010) Cumulative effective doses from radiologic procedures for pediatric oncology patients. Pediatrics 126:e851\u2013e858","journal-title":"Pediatrics"},{"key":"4511_CR30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/pbc.21599","volume":"51","author":"E Robbins","year":"2008","unstructured":"Robbins E (2008) Radiation risks from imaging studies in children with cancer. Pediatr Blood Cancer 51:453\u2013457","journal-title":"Pediatr Blood Cancer"},{"key":"4511_CR31","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/pbc.22575","volume":"55","author":"AL Chong","year":"2010","unstructured":"Chong AL, Grant RM, Ahmed BA et al (2010) Imaging in pediatric patients: time to think again about surveillance. Pediatr Blood Cancer 55:407\u2013413","journal-title":"Pediatr Blood Cancer"},{"key":"4511_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/bjh.15217","volume":"182","author":"S Goldman","year":"2018","unstructured":"Goldman S, Barth M, Hochberg J et al (2018) Reduced burden of oncologic therapy in children, adolescents and young adults with good risk (GR) CD20+ mature B-cell lymphoma. Br J Haematol 182:10","journal-title":"Br J Haematol"},{"key":"4511_CR33","first-page":"91","volume":"182","author":"JC Hochberg","year":"2018","unstructured":"Hochberg JC, Klejmont L, Harrison L et al (2018) Brentuximab vedotin and rituximab with reduced toxicity chemotherapy in children, adolescents and young adults with newly diagnosed Hodgkin lymphoma. Br J Haematol 182:91","journal-title":"Br J Haematol"},{"key":"4511_CR34","doi-asserted-by":"crossref","unstructured":"Bhakta N, Liu Q, Ness KK et al (2017) The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE). Lancet 390:2569\u20132582","DOI":"10.1016\/S0140-6736(17)31610-0"},{"key":"4511_CR35","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1056\/NEJM199603213341201","volume":"334","author":"S Bhatia","year":"1996","unstructured":"Bhatia S, Robison LL, Oberlin O et al (1996) Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 334:745\u2013751","journal-title":"N Engl J Med"},{"key":"4511_CR36","doi-asserted-by":"crossref","unstructured":"Bhatia S, Yasui Y, Robison LL et al (2003) High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. J Clin Oncol 21:4386\u20134394","DOI":"10.1200\/JCO.2003.11.059"},{"key":"4511_CR37","doi-asserted-by":"crossref","unstructured":"Bluhm EC, Ronckers C, Hayashi RJ et al (2008) Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood 111:4014\u20134021","DOI":"10.1182\/blood-2007-08-106021"},{"key":"4511_CR38","unstructured":"Ehrhardt MJ, Sandlund JT, Zhang N et al (2017) Late outcomes of adult survivors of childhood non-Hodgkin lymphoma: a report from the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer 64"},{"key":"4511_CR39","doi-asserted-by":"crossref","unstructured":"Holmqvist AS, Chen Y, Berano Teh J et al (2019) Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma \u2014 identification of high-risk populations to guide surveillance: a report from the Late Effects Study Group. Cancer 125:1373\u20131383","DOI":"10.1002\/cncr.31807"},{"key":"4511_CR40","unstructured":"Ehrhardt MJ, Chen Y, Sandlund JT et al (2019) Late health outcomes following contemporary Lymphome Malin de Burkitt therapy for mature B-cell non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. J Clin Oncol 8:JCO1900525"},{"key":"4511_CR41","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1055\/s-0042-110406","volume":"228","author":"W Dorffel","year":"2016","unstructured":"Dorffel W, Riepenhausen M, Luders H et al (2016) Late effects following treatment of Hodgkin lymphoma during childhood and adolescence. Results of the Hodgkin lymphoma late effects research project. Klin Padiatr 228:286\u2013293","journal-title":"Klin Padiatr"},{"key":"4511_CR42","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32:3059\u20133068","journal-title":"J Clin Oncol"}],"container-title":["Pediatric Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-019-04511-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00247-019-04511-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-019-04511-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T23:51:23Z","timestamp":1611532283000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00247-019-04511-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["4511"],"URL":"https:\/\/doi.org\/10.1007\/s00247-019-04511-4","relation":{},"ISSN":["0301-0449","1432-1998"],"issn-type":[{"value":"0301-0449","type":"print"},{"value":"1432-1998","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"11 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}